VaxCare

VaxCare's pricing strategy is highly disruptive in the healthcare space as it eliminates the 'Buy-and-Bill' financial burden. Instead of charging a SaaS subscription fee, VaxCare makes its platform available for free to qualified medical practices. The company purchases the practice's existing vaccine stock and provides all future inventory at no cost. VaxCare earns revenue by managing the billing process; they collect the reimbursement for the vaccine product from the insurance company and pay the practice the administration fee for each qualifying dose. This 'revenue-share' approach aligns VaxCare's success with the clinic's vaccination rates. For 'Partner Bill' scenarios (less than 10% of cases where VaxCare is out-of-network), the practice bills the insurance, and VaxCare then invoices the practice for the vaccine cost, ensuring the practice still benefits from the automated inventory and safety checks.